(Q61966833)
Statements
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intravenously Into Patients With Multiple Sclerosis (English)
0 references
April 2016
0 references
December 2018
0 references
0
0 references
18 year
0 references
80 year
0 references